Globe Life Inc. (NYSE:GL – Get Free Report) CEO Frank Svoboda sold 9,379 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at approximately $5,036,943.24. The trade was a 20.73% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Globe Life Price Performance
Shares of NYSE GL traded down $2.00 during trading on Wednesday, hitting $138.75. The company had a trading volume of 563,919 shares, compared to its average volume of 617,868. The firm has a market capitalization of $11.05 billion, a price-to-earnings ratio of 10.05 and a beta of 0.48. The stock has a fifty day simple moving average of $134.07 and a two-hundred day simple moving average of $132.89. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a fifty-two week low of $103.88 and a fifty-two week high of $147.83.
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The firm had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the prior year, the firm earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, research analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Dividend Announcement
Institutional Trading of Globe Life
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Public Sector Pension Investment Board grew its position in Globe Life by 3.3% in the first quarter. Public Sector Pension Investment Board now owns 22,472 shares of the company’s stock worth $2,960,000 after acquiring an additional 715 shares during the period. Kovitz Investment Group Partners LLC lifted its stake in shares of Globe Life by 2.9% in the 1st quarter. Kovitz Investment Group Partners LLC now owns 3,609 shares of the company’s stock valued at $475,000 after purchasing an additional 102 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Globe Life by 41.9% during the 1st quarter. American Century Companies Inc. now owns 205,421 shares of the company’s stock worth $27,058,000 after purchasing an additional 60,606 shares during the period. Cresset Asset Management LLC acquired a new stake in shares of Globe Life during the 1st quarter worth about $253,000. Finally, Steward Partners Investment Advisory LLC raised its holdings in Globe Life by 1.0% in the 1st quarter. Steward Partners Investment Advisory LLC now owns 24,914 shares of the company’s stock valued at $3,282,000 after buying an additional 249 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.
Analysts Set New Price Targets
GL has been the topic of several recent research reports. Wells Fargo & Company lowered their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Cowen restated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Truist Financial upped their price objective on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Morgan Stanley reissued an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research note on Monday. Finally, Piper Sandler restated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. Nine analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $164.89.
Read Our Latest Stock Analysis on GL
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Following Congress Stock Trades
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
